Universal Ibogaine Inc. (TSXV:IBO)
0.0050
-0.0050 (-50.00%)
Feb 2, 2026, 9:30 AM EST
Universal Ibogaine Balance Sheet
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 0.13 | 0.37 | 0.31 | 0.73 | 0.14 | 2.17 |
Cash & Short-Term Investments | 0.13 | 0.37 | 0.31 | 0.73 | 0.14 | 2.17 |
Cash Growth | -72.83% | 18.37% | -56.85% | 410.60% | -93.45% | 4030.37% |
Accounts Receivable | 0.61 | 0.19 | 0.08 | - | - | - |
Other Receivables | - | - | - | 0.23 | 0.11 | 0.02 |
Total Trade Receivables | 0.61 | 0.19 | 0.08 | 0.23 | 0.11 | 0.02 |
Other Current Assets | 0.05 | 0.48 | 0.05 | 0.06 | 0.65 | 0.01 |
Total Current Assets | 0.78 | 1.04 | 0.44 | 1.02 | 0.9 | 2.2 |
Net Property, Plant & Equipment | 3.22 | 3.47 | 3.66 | 5.3 | 3.05 | 0 |
Other Long-Term Assets | - | - | 1.4 | - | 0.04 | - |
Total Assets | 4.01 | 4.51 | 5.5 | 6.32 | 3.99 | 2.2 |
Accounts Payable | 0.77 | 0.73 | 0.87 | 0.64 | 0.64 | 0.07 |
Short-Term Debt | 0.72 | - | - | - | 0.35 | - |
Current Portion of Long-Term Debt | 0.11 | 0.11 | 1.8 | 1.56 | - | - |
Current Portion of Leases | 0.02 | 0.02 | 0.02 | - | - | - |
Unearned Revenue | 0.39 | 0.14 | 0.11 | - | - | - |
Other Current Liabilities | - | - | - | - | - | 2.07 |
Total Current Liabilities | 2.01 | 1 | 2.79 | 2.19 | 0.99 | 2.14 |
Long-Term Debt | 1.68 | 2.47 | 0.94 | 0.18 | 0.06 | 0.06 |
Long-Term Leases | 0.04 | 0.06 | 0.02 | - | - | - |
Total Long-Term Liabilities | 1.72 | 2.52 | 0.96 | 0.18 | 0.06 | 0.06 |
Total Liabilities | 3.73 | 3.52 | 3.75 | 2.37 | 1.05 | 2.2 |
Common Stock | 24.15 | 24.15 | 22.84 | 22.8 | 13.79 | 0.79 |
Additional Paid-in Capital | 4.02 | 4.02 | 4.04 | 3.88 | 1.4 | 0.12 |
Accumulated Other Comprehensive Income | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | - |
Retained Earnings | -27.9 | -27.18 | -25.13 | -22.74 | -12.25 | -0.92 |
Shareholders' Equity | 0.27 | 0.99 | 1.75 | 3.94 | 2.94 | -0 |
Total Liabilities & Equity | 4.01 | 4.51 | 5.5 | 6.32 | 3.99 | 2.2 |
Total Debt | 2.57 | 2.65 | 2.78 | 1.74 | 0.41 | 0.06 |
Net Cash (Debt) | -2.44 | -2.28 | -2.46 | -1.01 | -0.27 | 2.11 |
Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | 0.22 |
Book Value | 0.27 | 0.99 | 1.75 | 3.94 | 2.94 | -0 |
Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | -0.00 |
Tangible Book Value | 0.27 | 0.99 | 1.75 | 3.94 | 2.94 | -0 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | -0.00 |